IN2014DE00935A - - Google Patents

Download PDF

Info

Publication number
IN2014DE00935A
IN2014DE00935A IN935DE2014A IN2014DE00935A IN 2014DE00935 A IN2014DE00935 A IN 2014DE00935A IN 935DE2014 A IN935DE2014 A IN 935DE2014A IN 2014DE00935 A IN2014DE00935 A IN 2014DE00935A
Authority
IN
India
Prior art keywords
angiogenesis
derived
treatment
lox
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Natarajan Sulochana Koneriajapuram
Arun Mohan
Bhuvanasundar Renganathan
Coral Karunakaran
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to IN935DE2014 priority Critical patent/IN2014DE00935A/en
Publication of IN2014DE00935A publication Critical patent/IN2014DE00935A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN935DE2014 2014-04-01 2014-04-01 IN2014DE00935A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN935DE2014 IN2014DE00935A (enExample) 2014-04-01 2014-04-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN935DE2014 IN2014DE00935A (enExample) 2014-04-01 2014-04-01

Publications (1)

Publication Number Publication Date
IN2014DE00935A true IN2014DE00935A (enExample) 2015-10-09

Family

ID=54395040

Family Applications (1)

Application Number Title Priority Date Filing Date
IN935DE2014 IN2014DE00935A (enExample) 2014-04-01 2014-04-01

Country Status (1)

Country Link
IN (1) IN2014DE00935A (enExample)

Similar Documents

Publication Publication Date Title
ZA201705114B (en) Cysteine protease
ZA201705113B (en) Cysteine protease
PH12018500016A1 (en) Agents, uses and methods for the treatment of synucleinopathy
MX2017003358A (es) Compuestos novedosos.
NZ735044A (en) Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
LT3204015T (lt) Kompozicijos ir būdai, skirti hao1 (hidroksirūgšties oksidazė 1 (glikolato oksidazė)) genų raiškos slopinimui
EP4218785A3 (en) Mitochondria-targeting peptides
MX2013000958A (es) Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
MX2016011745A (es) Variantes de hppd y metodos de uso.
EP4219715A3 (en) Stabilized cebpa sarna compositions and methods of use
MX2018016037A (es) Variantes de lipasa y composiciones que comprenden tensioactivo y variante de lipasa.
AR101811A1 (es) Anticuerpo monoclonal humanizado que inhibe la actividad enzimática de la lipasa endotelial vascular
MX2019000508A (es) Radioligandos para formar la imagen de la enzima indolamina 2,3-dioxigenasa (ido1).
PH12020551618A1 (en) Erenumab compositions and uses thereof
MX2020004058A (es) Inhibidores de d-aminoacido oxidasa y sus usos terapeuticos.
NZ758427A (en) Lactase enzymes with improved activity at low temperatures
PH12017502277A1 (en) Multi-specific binding proteins
PH12017501549B1 (en) Peptides for inhibiting angiogenesis
NZ732301A (en) Peptide compound, preparation method therefor, and application thereof
MX2015002279A (es) Peptido pntx(19) sintético, composición farmacéutica.y uso.
EP3681526A4 (en) PEPTIDIC INHIBITORS OF INSULIN DEGRADATION ENZYME
MA40642A (fr) Nouveaux dérivés peptidiques et leurs utilisations
IN2014DE00935A (enExample)
EA201791456A1 (ru) Пептиды-антагонисты cgrp
MX2025005101A (es) Composiciones y metodos para tratar o prevenir la taquicardia ventricular polimorfica catecolaminergica